Amgen

BLINCYTO

  1. Home
  2.  / 
  3. J Code
  4.  / BLINCYTO – J9039

Manufacturer:

Amgen

Name:

BLINCYTO

Category:

J Code

HCPCS:

J9039

NDC(s):

55513-0160-01,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

BLINCYTO is a Cancer drug manufactured by Amgen and administered via the Intravenous route of administration. The J Code: J9039 is aligned to the drug BLINCYTO.

Access Pricing and More By Registering